Immunotherapy for neuroblastoma using mRNA vaccines
Author:
Open Access
- 4 March 2022
- journal article
- research article
- Published by Elsevier in Advances in Cancer Biology - Metastasis
- Vol. 4
Abstract
No abstract availableKeywords
This publication has 163 references indexed in Scilit:
- Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk NeuroblastomaCancer Cell, 2017
- Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat dietPhysiology & Behavior, 2017
- Genetic susceptibility to neuroblastomaCurrent Opinion in Genetics & Development, 2017
- Type 1 diabetes vaccine candidates promote human Foxp3+Treg induction in humanized miceNature Communications, 2016
- mRNA-based therapeutics — developing a new class of drugsNature Reviews Drug Discovery, 2014
- Nanomedicines for back of the eye drug delivery, gene delivery, and imagingProgress in Retinal and Eye Research, 2013
- Neuroblastoma: developmental biology, cancer genomics and immunotherapyNature Reviews Cancer, 2013
- Cancer immunotherapy: a paradigm shift for prostate cancer treatmentNature Reviews Urology, 2012
- Immunology and immunotherapy of neuroblastomaSeminars in Cancer Biology, 2011
- Technology Insight: vaccine therapy for prostate cancerNature Reviews Endocrinology, 2005